Related Experiment Video
Updated: Mar 15, 2026

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
Published on: December 6, 2016
Clinical Spectrum of Medium-Sized Vessel Vasculitis
Fatma Alibaz-Oner1, Matthew J Koster1, Cynthia S Crowson1
1Mayo Clinic, Rochester, Minnesota.
Objective:
Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis of medium-sized visceral vessels. However, cutaneous arteritis (CA) and gastrointestinal (GI) vasculitis are forms of single-organ vasculitis having indistinguishable histopathologic findings from PAN. The aim of this study was to evaluate and compare the clinical characteristics, treatment, and outcomes of patients with systemic PAN, CA, and GI vasculitis.
Methods:
Retrospective cohorts were assembled, consisting of patients with PAN, CA, and GI vasculitis between 1980 and 2014. The demographics, clinical characteristics, treatment, and outcomes of patients were abstracted from medical records.
Results:
We included 48 patients with PAN, 41 patients with CA, and 19 patients with GI vasculitis. The disease of 1 patient evolved from CA to systemic PAN during the disease course. At diagnosis, 94% of patients with PAN, 93% of patients with CA, and 67% of patients with GI vasculitis were treated with glucocorticoids. Additional immunosuppressive agents were used in 67% of PAN, 37% of GI vasculitis, and 32% of CA cases. The 5-year cumulative relapse rate was 45.2% in CA, and only 9.6% in PAN during a followup of approximately 6 years. No deaths were observed in the CA group. The survival rate at 10 years was 66% in the PAN group and 61% in the GI vasculitis group.
Conclusion:
Systemic PAN, CA, and GI vasculitis take different clinical courses and therefore may be different diseases, rather than existing on a spectrum of the same disease. Progression of CA to systemic PAN is very rare. Relapse risk is low during followup in PAN. Patients with CA have a higher relapse rate than those with systemic PAN, possibly due to less use of immunosuppressive therapy in CA.
Insights
Polyarteritis nodosa (PAN), cutaneous arteritis (CA), and gastrointestinal (GI) vasculitis may represent distinct diseases, not a disease spectrum. CA patients experience higher relapse rates than PAN patients, suggesting different treatment needs.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Polyarteritis nodosa (PAN) is a systemic vasculitis affecting medium-sized visceral vessels.
- Cutaneous arteritis (CA) and gastrointestinal (GI) vasculitis share histopathologic features with PAN but are considered single-organ vasculitides.
- Distinguishing between systemic PAN and its single-organ variants is crucial for understanding disease course and management.
Purpose of the Study:
- To compare the clinical characteristics, treatment strategies, and patient outcomes across systemic PAN, CA, and GI vasculitis.
- To investigate whether these conditions represent a spectrum of the same disease or distinct entities.
- To identify factors influencing disease relapse and survival in different vasculitis presentations.
Main Methods:
- Retrospective cohort study of patients diagnosed with PAN, CA, or GI vasculitis between 1980 and 2014.
- Data abstraction from medical records included demographics, clinical features, treatment regimens, and outcomes.
- Comparative analysis of disease course, relapse rates, and survival between the three groups.
Main Results:
- The study included 48 patients with PAN, 41 with CA, and 19 with GI vasculitis.
- Glucocorticoids were common initial treatments for all groups; additional immunosuppressants were more frequent in PAN.
- CA exhibited a significantly higher 5-year cumulative relapse rate (45.2%) compared to PAN (9.6%), with no deaths observed in the CA group. 10-year survival rates were 66% for PAN and 61% for GI vasculitis.
Conclusions:
- Systemic PAN, CA, and GI vasculitis demonstrate different clinical trajectories, suggesting they may be distinct diseases.
- Progression from CA to systemic PAN is rare.
- Higher relapse rates in CA patients may be linked to less frequent use of immunosuppressive therapy compared to PAN.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Overview of Systemic Arteries
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Vascular Spasm
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

